Showing 6,741 - 6,760 results of 30,876 for search '(( 5 wt decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.95s Refine Results
  1. 6741
  2. 6742

    LM11A-31's effect on cholinergic dystrophic neurites in cortex of mid-stage APP<sup>L/S</sup> mice. by Danielle A. Simmons (621167)

    Published 2014
    “…Scale bar in photomicrograph A = 50 µm. Quantitative analysis showed that LM11A-31 decreases the total area occupied by the clusters (<b><i>C</i></b>) by decreasing their number (<b><i>D</i></b>) but not the mean area per cluster (<b><i>E</i></b>). …”
  3. 6743
  4. 6744

    Removal of specific N-glycans can alter neutralization potency and completeness. by Sabrina Lusvarghi (2329267)

    Published 2023
    “…<p>(A) Structure of SARS-CoV-2 spike in the closed conformation complexed with Bebtelovimab (PDBID:7MMO, yellow), C135 (PDBID: 7K8Z, green) and S309 (red, PDBID: 6WPS). …”
  5. 6745
  6. 6746

    Sensitivity of U251 stable clones to GCV. by Elizabeth Wei-Chia Luo (11250668)

    Published 2021
    “…<p>U251, U251-pCMV-HSVtk, and U251-pGFAP-HSVtk cells were treated with 0, 1, 5, or10 μg/ml of GCV for 5 days. (A–D) Live-cell phase images of U251 parent cells displayed no cytotoxicity up to 10 μg/ml of GCV. …”
  7. 6747

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…Adherence (≥80%) was seen to increase with age (77.6%, 18–30 years; 79.6%, 31–40 years; 81.3%, 41–50 years; 84.0%, ≥51 years), at the same time as a non-significant decrease in discontinuation (incidence rate: 79.91, 73.01, 71.75, 68.71%).…”
  8. 6748

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…Adherence (≥80%) was seen to increase with age (77.6%, 18–30 years; 79.6%, 31–40 years; 81.3%, 41–50 years; 84.0%, ≥51 years), at the same time as a non-significant decrease in discontinuation (incidence rate: 79.91, 73.01, 71.75, 68.71%).…”
  9. 6749

    3D spheroids enhance NFAT3 and CXCR4 expression. by Keven Huang (675616)

    Published 2014
    “…(<b>C</b>) Corresponding to the increase in NFAT3 in 3D spheroids, real-time PCR showed a 30-50-fold increase in CXCR4 mRNA in 3D spheroids when compared to adherent HeyA8 cells. (*, P <0.05 vs Adh, 1-way ANOVA). …”
  10. 6750
  11. 6751

    Patterns of nestin, GFAP, and βIII-tubulin expression in U251-pCMV-HSVtk cells. by Elizabeth Wei-Chia Luo (11250668)

    Published 2021
    “…Immunocytochemistry of nestin (A–F), GFAP (G–L), and βIII-tubulin (M–R, M′–R′) was performed to characterize the identity of surviving cells. …”
  12. 6752

    Hap2p and Hap5p transcription factors are required for lactate assimilation and virulence. by Keigo Ueno (206625)

    Published 2011
    “…(B) Lactate assimilation was decreased in Δhap2 and Δhap5 strains. Strains were cultivated on lactate plates (2% agar,pH 5.0) for 3 days at 37°C (Upper panel), and in liquid medium containing 2% L-lactate for 5 days at 37°C. …”
  13. 6753
  14. 6754
  15. 6755

    TLR4 and RAGE were involved in HMGB1-induced activation of NF-κB in bEnd.3 cells. by Yan Chen (4308)

    Published 2015
    “…Inhibition of TLR4 and RAGE resulted in a significant decrease in HMGB1-induced NF-κB p65 translocation to nuclei. …”
  16. 6756
  17. 6757

    Loss of MBNL1 enhances rotarod deficits in SCA8 BAC-EXP5 mice. by Randy S. Daughters (260834)

    Published 2009
    “…Individual trial day data points are the average of the last 3 trials and show a decreased latency for SCA8<sup>+/−</sup>; <i>Mbnl1</i><sup>+/ΔE3</sup> mice that is significantly different from WT at day four. …”
  18. 6758
  19. 6759

    The effects of purmorphamine and Msi1 knockdown on miR-148a and miR-148b expression. by In-Sun Hong (284033)

    Published 2013
    “…The expression levels of miR-148a (<b>A</b>) and miR-148b (<b>B</b>) were decreased by purmorphamine treatment. …”
  20. 6760